About NuCana plc
https://www.nucana.comNuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology.
CEO
Hugh Stephen Griffith
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2025-08-08 | Reverse | 1:200 |
| 2024-04-16 | Reverse | 1:25 |
Ratings Snapshot
Rating : B
Price Target
Institutional Ownership
SOFINNOVA MANAGEMENT VIII, L.L.C.
Shares:4.67M
Value:$15.54M
ABINGWORTH LLP
Shares:3.33M
Value:$11.1M
SUNTRUST BANKS INC
Shares:70.1K
Value:$233.43K
Summary
Showing Top 3 of 4
About NuCana plc
https://www.nucana.comNuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $0 | $779K ▼ | $-281K ▲ | 0% | $-0.07 ▲ | $-3.5M ▲ |
| Q2-2025 | $0 | $11.83M ▲ | $-24.11M ▼ | 0% | $-23.25 ▼ | $-11.56M ▼ |
| Q1-2025 | $0 | $2.85M ▲ | $-2.47M ▼ | 0% | $-0.5 ▼ | $-2.73M ▼ |
| Q4-2024 | $0 | $865K ▼ | $-653K ▲ | 0% | $-0.12 ▲ | $-1.15M ▲ |
| Q3-2024 | $0 | $5.32M | $-4.51M | 0% | $-0.88 | $-4.96M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $25.25M ▲ | $32.31M ▲ | $6.39M ▼ | $25.93M ▲ |
| Q2-2025 | $8.44M ▲ | $16.22M ▲ | $8.83M ▲ | $7.38M ▲ |
| Q1-2025 | $3.95M ▼ | $11.6M ▼ | $7.43M ▼ | $4.17M ▼ |
| Q4-2024 | $6.75M ▼ | $14.77M ▼ | $8.82M ▼ | $5.95M ▲ |
| Q3-2024 | $11.35M | $19.53M | $15.19M | $4.35M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-281K ▲ | $1.28M ▲ | $64K ▲ | $15.24M ▲ | $16.81M ▲ | $1.23M ▲ |
| Q2-2025 | $-24.11M ▼ | $-4.49M ▼ | $-28K ▼ | $9.32M ▲ | $4.49M ▲ | $-4.54M ▼ |
| Q1-2025 | $-2.47M ▼ | $-3.11M ▲ | $-11K ▼ | $442K ▼ | $-2.8M ▲ | $-3.15M ▲ |
| Q4-2024 | $-653K ▲ | $-7.46M ▼ | $22K ▲ | $2.19M ▼ | $-4.6M ▼ | $-7.51M ▼ |
| Q3-2024 | $-4.51M | $-4.6M | $18K | $4.68M | $-288K | $-4.67M |
CEO
Hugh Stephen Griffith
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2025-08-08 | Reverse | 1:200 |
| 2024-04-16 | Reverse | 1:25 |
Ratings Snapshot
Rating : B
Price Target
Institutional Ownership
SOFINNOVA MANAGEMENT VIII, L.L.C.
Shares:4.67M
Value:$15.54M
ABINGWORTH LLP
Shares:3.33M
Value:$11.1M
SUNTRUST BANKS INC
Shares:70.1K
Value:$233.43K
Summary
Showing Top 3 of 4